ClinicalTrials.gg
RecruitingNCT05857813Updated Jul 31, 2026

Social Skills Training Group Effectiveness in Adolescents With Autism Spectrum Disorder

An interventional study of Program for the Education and Enrichment of Relational Skills (PEERS®) in Autism Spectrum Disorder, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 11 Years to 20 Years. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jan 2022, registered Apr 2023).
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
11 Years to 20 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Autism Spectrum Disorder by National Taiwan University Hospital — 14 open to participants now, 16 under way, none of them phase 3. Autism Spectrum Disorder · National Taiwan University Hospital.

Planned enrollment
Largest of 20
120 · median 55
Started
2022
with 3 others
No phase
20 of 42
11 open now
Primary completion
2027-07
later than 8 of 15 live
Registered
24th of 42
by date

Among the 42 studies in Autism Spectrum Disorder by National Taiwan University Hospital, this one has the largest planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2022, is one of 20 with no phase, reaches primary completion later than 8 of the 15 other live ones, and was the 24th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

14 of the 42 studies in Autism Spectrum Disorder by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 11 Years to 20 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Autism Spectrum Disorder by National Taiwan University Hospital, or all of them as a file.
02

Study summary

Autism spectrum disorders (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction across multiple contexts, and the presence of restricted, repetitive behavior and interests, affecting 1 in 68 children. Although atypical social deficits onset in early childhood, their social relationships with peers may remain a challenge or even worsen for individuals with ASD throughout the school years and beyond, as social contexts increase in complexity and pose higher social expectations.

03

Conditions studied

  • Autism Spectrum Disorder
04

Who can participate

Ages eligible
11 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 11-20 years, currently enrolled in school between the sixth grade of elementary school and the third year of high school
  • with a clinical diagnosis of ASD from a licensed mental health or medical professional based on
  • experiencing social difficulties as reported by parents in a structured intake interview
  • scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD
  • demonstrating verbal fluency in Chinese
  • with a full-scale IQ > 70 on WAIS-IV
  • with motivation to participate in the intervention;
  • with a caregiver who was fluent in Chinese and willing to participate as a social coach in the study.

Exclusion criteria

Exclusion Criteria:

  • a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis) or neurological diseases that might hinder participation in the treatment
  • visual impairment and/or hearing impairment that would preclude participation in group-based social activities.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    ASD teens and their caregiver

    Teens: (1) aged 11-20 years, currently enrolled in school between the sixth grade of elementary school and the third year of high school; (2) with a clinical diagnosis of ASD from a licensed mental health or medical professional based on DSM-5; (3) experiencing social difficulties as reported by parents in a structured intake interview; (4) scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD (5) demonstrating verbal fluency in Chinese (6) with a full-scale IQ \> 70 on WAIS-IV; (7) with motivation to participate in the intervention; (8) with a caregiver who was fluent in Chinese and willing to participate as a social coach in the study. Parents: (1) demonstrating verbal fluency in Chinese (2) with motivation to participate in the intervention and assist their children to do the homework assignments.

    Behavioral: Program for the Education and Enrichment of Relational Skills (PEERS®)

Interventions

  • BehavioralProgram for the Education and Enrichment of Relational Skills (PEERS®)

    developed at the University of California, Los Angeles (E. A. Laugeson \& F. Frankel, 2010). This is a parent-assisted, manualized social skills training program that addresses crucial areas of social functioning for adolescents. Psycho-education and cognitive-behavioral therapy techniques are employed to help adolescents develop ecologically valid skills for making and maintaining friendships.

06

What researchers measure

Primary outcomes

  1. Autism Diagnostic Interview-Revised (ADI-R)

    Interview with caregiver of autistic participants. Total of 93 items coding from 1 to 9. Higher the score, worse the syptom

    Time frame: 7 weeks

  2. The Autism Diagnostic Observation Schedule (ADOS)

    Observe the autistic participant during the interview. the examinee's condition is classified as autism spectrum if the combined score across two domains of social interaction and communication is ≥7, and as autism if the combined score is ≥12. In Module 2, a combined score of ≥8 corresponds to autism spectrum, and a combined score of ≥12 corresponds to autism

    Time frame: 7 weeks

  3. Autism Spectrum Quotient (AQ)

    50 statement scoring from 1 to 4. higher the score, worse the syptom

    Time frame: 7 weeks

  4. Friendship Quality Scale (FQS)

    23 questions scoring from 1 to 5. Higher the score, better the quality of friendship

    Time frame: 7 weeks

  5. The Assessing Emotions Scale (AES)

    score range from 33 to 165. higher the score, better the emotional intelligence

    Time frame: 7 weeks

  6. Social Responsiveness Scale (SRS)

    65 questions range from 1 to 4. higher the score, worse the symptom.

    Time frame: 7 weeks

  7. Social Adjustment Inventory for Children and Adolescents (SAICA)

    17 scenarios scoring from 1 to 4. Higher the score, better the capability

    Time frame: 7 weeks

  8. Quality of Play Questionnaire (QPQ)

    10 questions scoring from 0 to 3. Higher the score, worse the quality of play. Also, asked for frequency and number of participant in the play

    Time frame: 7 weeks

  9. Test of Adolescents Social Skills Knowledge (TASSK)

    score range from 0 to 22. Higher the score, greater the knowledge of taught social skills

    Time frame: 7 weeks

  10. Empathy Quotient (EQ)

    60 questions score from 0 to 3. Higher the score, greater the empathy

    Time frame: 7 weeks

  11. Friendship Questionnaire (FQ)

    score from 0 to 135. higher the score, the more enjoyment of friendship

    Time frame: 7 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Jul 2027, 66 months after the start.

Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 66 months is above that.

Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2023
First posted
May 15, 2023
StartActual
Jan 1, 2022
Primary completionEst.
Jul 12, 2027
CompletionEst.
Jul 12, 2027
Last update
Jul 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05857813
Responsible party
Sponsor
First posted
May 15, 2023
Start date
Jan 1, 2022
Primary completion
Jul 12, 2027 (estimated)
Completion
Jul 12, 2027 (estimated)
Last update
Jul 31, 2026

Study contacts

Yi-Ling Chien
Contact
chienyiling@gmail.com
+886223123456#66013

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion